S&P Futures
5,966.25 +8.00 (+0.13%) Dow Futures
43,975.00 +74.00 (+0.17%) Nasdaq Futures
20,938.50 +44.50 (+0.21%) Russell 2000 Futures
2,408.10 +2.30 (+0.10%) Crude Oil
71.58 -0.11 (-0.15%) Gold
2,670.30 -6.00 (-0.22%)
PharmaTher Holdings Ltd. (PHRRF)
| Previous Close | 0.1710 |
| Open | 0.1661 |
| Bid | 0.1710 x 0 |
| Ask | 0.1728 x 0 |
| Day's Range | 0.1661 - 0.1661 |
| 52 Week Range | 0.0850 - 0.3200 |
| Volume | |
| Avg. Volume | 246,534 |
| Market Cap | 15.675M |
| Beta (5Y Monthly) | 3.39 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0400 |
| Earnings Date | Oct 21, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswirePharmaTher Receives Complete Response Letter from the U.S. Food and Drug Administration for Ketamine Abbreviated New Drug Application
TORONTO, Oct. 23, 2024 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter (CRL), dated October 22, 2024, for the ketamine Abbreviated New Drug Application, which was assigned a Generic Drug User Fee Amendments of 2022 (“GDUFA”) goal date of October 29, 2024. The deficiencies cited in the CRL are classified
Simply Wall St.TSX Penny Stocks To Consider In October 2024
The Canadian market has seen a notable upswing, with a 1.0% increase over the last week and an impressive 27% rise in the past year, alongside forecasts of annual earnings growth at 16%. In light of these conditions, identifying stocks with strong fundamentals becomes crucial for investors seeking potential growth opportunities. Penny stocks may be considered a dated term, but they continue to represent viable investment options by offering access to smaller or newer companies that could...
